Avorstatin-calcium-structure (Avorstatin Calcium Structure)
Lypqozet
Product Images NDC 70661-005
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lypqozet (NDC 70661-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Althera Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Ezetimibe-structure (Ezetimibe Structure)
Label-10-10-30 (Label 10 10 30)
This is a description of a medication containing both ezetimibe and atorvastatin calcium used to treat high cholesterol levels in adults. The medication is in the form of film-coated tablets, with each tablet containing 10 mg of ezetimibe and 10.34 mg of atorvastatin calcium. The tablets are manufactured in India and distributed by Althera Pharmaceuticals LLC, with a recommended dosage outlined in the package insert. The medication should be stored in a tightly sealed container at room temperature and protected from moisture and light.*
Label-10-10-90 (Label 10 10 90)
This is a description of a medication that comes in film-coated tablets containing 10 mg of ezetimibe, USP and 10.34 mg of atorvastatin calcium, USP, equivalent to 10 mg of atorvastatin. The tablets are distributed by Althera Pharmaceuticals LLC and manufactured for SCOV3 Sciences Ltd, both in the USA. The tablets should be kept in a tight, light resistant container between 15°C to 30°C, and protected from moisture and light. Usual adult dosage should be confirmed in the package outsert, and prescribing information is available upon request.*
Label-10-20-30 (Label 10 20 30)
This is a medication called ezetimibe and atorvastatin calcium which is distributed by Althera Pharmaceuticals LLC in film-coated tablet form. The tablets come in 10mg and 20mg variants with the usual adult dosage mentioned in the package outsert. The tablets are manufactured in India and should be stored in a tight, light-resistant container between 15°C and 30°C to protect them from moisture and light. This is a prescription medication and should be kept out of reach of children. There is a code MP/DRUGS/25/10/92 mentioned in the description.*
Label-10-20-90 (Label 10 20 90)
This is a description of a medication containing 10 mg of ezetimibe, USP and 20.68 mg of atorvastatin calcium, USP equivalent to 20 mg of atorvastatin. The tablets are film-coated and distributed by Althera Pharmaceuticals LLC. The manufacturer is not specified but the tablets are made in India. Adult dosage information is available on the package outsert. The medication should be kept in a tight, light-resistant container at a temperature between 15°C to 30°C and protected from moisture and light. This medication is available only with a prescription.*
Label-10-40-30 (Label 10 40 30)
LYPQOZET tablets contain 10 mg of ezetimibe, USP, and 41.37 mg of atorvastatin calcium, USP, which is equal to 40 mg of atorvastatin. These film-coated tablets should be kept in a tightly sealed, light-resistant container and placed away from moisture and light. It is essential to keep them out of reach of children. The package outsert should be referred to for the complete prescribing information regarding the usual adult dosage. The tablets should be stored between 20°C to 25°C (68°F to 77°F), with excursions up to 15°C to 30°C (59°F to 86°F) permitted as per USP Controlled Room Temperature conditions. Althera Pharmaceuticals LLC distributes LYPQOZET, and SCOV3 Sciences Ltd. manufactures it for Althera. The tablets are made in India, and the code provided on the package is MP/DRUGS/25/10/92.*
Label-10-40-90 (Label 10 40 90)
This is a medication called ezetimibe and atorvastatin calcium tablets. Each film-coated tablet contains 10mg of ezetimibe, USP and 41.37mg of atorvastatin calcium, USP, which is equivalent to 40mg of atorvastatin. The tablets are manufactured for I SCOV3 Sciences Ltd. and distributed by an LLC in Morristown, NJ, USA. The package insert provides further information on adult dosage and prescribing information. The tablets should be stored in a tight, light-resistant container between 15°C to 30°C and protected from moisture and light. This is a prescription drug intended for use under medical supervision only.*
Label-10-80-30 (Label 10 80 30)
This is a medication containing both ezetimibe and atorvastatin calcium in 10mg and 82.73mg quantities respectively, equivalent to 80mg of atorvastatin, in a film-coated tablet form. It is intended for adults and is dispensed in a tight, light-resistant container. The usual adult dosage and full prescribing information is available in the package outsert. It should be stored between 20°C to 25°C and protected from moisture and light. This medication is distributed by Althera Pharmaceuticals LLC in Morristown, NJ, and manufactured for SCOV3 Sciences Ltd. There is a code printed on the packaging as MP/DRUGS/25/10/92. The text includes some errors.*
Label-10-80-90 (Label 10 80 90)
This text describes medication containing 10mg of ezetimibe and 82.73mg of atorvastatin calcium, equivalent to 80mg of atorvastatin, available in a container that protects from light and moisture. The medication is recommended for adults according to the instructions provided in the package outsert. It is manufactured for SCOV3 Sciences Ltd. in India and distributed by Althera Pharmaceuticals LLC in the USA. The document also includes the dosage, storage instructions, and safety precautions.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
